发明名称 |
Combination therapy using an anti-EGFR agent(s) and IGF-1R specific inhibitors |
摘要 |
The combination of an IGF-1R antagonist such as a humanized antibody and an anti-proliferative drug is described. In a preferred embodiment, the present invention describes the combination of an IGF-1R antibody and an anti-proliferative drug belonging to the EGFR-inhibitor class, which is preferably erlotinib. The combination according to the present invention is useful for the treatment of tumours, including IGF-1R and /or EGFR mediated or dependent tumours. |
申请公布号 |
AU2010236818(B2) |
申请公布日期 |
2014.03.13 |
申请号 |
AU20100236818 |
申请日期 |
2010.04.06 |
申请人 |
MERCK SHARP & DOHME CORP. |
发明人 |
SATHYANARAYANAN, SRIRAM;KASIBHATLA, SHAILAJA;WINTER, CHRISTOPHER;CHASTAIN, MICHAEL |
分类号 |
A61K39/395;A61K31/517 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|